FFCP PHASE1:Hg19::chr10:49880649..49880677,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr10:49880649..49880677,+ | |||
|coexpression_cluster_id=C782 | |||
|description=CAGE_peak_at_chr10:49880649..49880677,+ | |||
|id=chr10:49880649..49880677,+ | |||
|ontology_enrichment_celltype=CL:0000945!1.37e-128!24;CL:0000826!1.37e-128!24;CL:0000236!2.92e-72!14;CL:0000542!7.96e-62!53;CL:0000051!7.96e-62!53;CL:0000838!2.28e-57!52;CL:0002087!4.20e-25!119;CL:0002031!1.29e-21!124;CL:0000738!9.19e-21!140;CL:0002032!5.06e-17!165;CL:0000837!5.06e-17!165;CL:0000037!3.62e-16!172;CL:0000566!3.62e-16!172;CL:0000785!2.08e-15!2;CL:0000955!2.08e-15!2;CL:0000818!2.08e-15!2;CL:0000954!2.08e-15!2;CL:0000816!2.08e-15!2;CL:0000988!4.63e-15!182;CL:0000817!1.41e-10!3;CL:0000819!1.27e-08!1;CL:0000946!1.71e-08!1;CL:0000786!1.71e-08!1;CL:0000980!1.71e-08!1 | |||
|ontology_enrichment_celltype_v019=CL:0000945;5.16e-98;24!CL:0000236;2.11e-68;13!CL:0000542;7.31e-31;53!CL:0000785;2.38e-15;1!CL:0000819;2.38e-15;1!CL:0002087;2.53e-07;104!CL:0000738;3.56e-07;136 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,5.18e-98,24;CL:0000826,5.18e-98,24;CL:0000236,1.66e-63,14;CL:0000838,9.97e-45,52;CL:0000542,7.28e-44,53;CL:0000051,7.28e-44,53;CL:0002087,2.02e-19,115;CL:0002031,1.44e-18,120;CL:0000738,2.98e-16,136;CL:0000819,2.75e-15,1;CL:0002032,1.53e-13,161;CL:0000837,1.53e-13,161;CL:0000037,6.31e-13,168;CL:0000988,3.33e-12,177;CL:0000785,2.67e-08,2;CL:0000955,2.67e-08,2;CL:0000818,2.67e-08,2;CL:0000954,2.67e-08,2;CL:0000816,2.67e-08,2 | |||
|ontology_enrichment_development_v019=CL:0000051;7.31e-31;53!CL:0000954;2.48e-08;2 | |||
|ontology_enrichment_disease=DOID:0060058!1.84e-25!10;DOID:0060073!1.27e-08!1;DOID:8675!1.27e-08!1;DOID:12603!2.64e-08!1;DOID:630!3.06e-08!1;DOID:0050177!3.06e-08!1;DOID:0050427!3.06e-08!1;DOID:2355!4.07e-08!1 | |||
|ontology_enrichment_disease_v019=DOID:0060058;6.62e-23;10!DOID:0060073;2.38e-15;1!DOID:8675;2.38e-15;1 | |||
|ontology_enrichment_disease_v019_2=DOID:0060058,7.85e-23,10;DOID:0060073,2.75e-15,1;DOID:8675,2.75e-15,1 | |||
|ontology_enrichment_uberon=UBERON:0002372!3.53e-08!1;UBERON:0001961!3.53e-08!1;UBERON:0001744!3.53e-08!1;UBERON:0001735!3.53e-08!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.59805579543034,2.54511827294832,2.20390187678302,0,0,0,0,0,0,0.774672005803016,5.40243083452202,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.75996244461323,2.18455444504853,0,2.56038133539904,1.60158394814405,2.29900975981793,1.32208974556972,0.954053754535364,1.1384259382189,0.587237189370939,0.764546456250458,0,0.560508562981536,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.764637207142375,0,0,0,0,0,0,0,0,0,0.371606350251437,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369254416383208,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.27718352450966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0846733320657845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.21792598380896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.921871900446234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.29923502702408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.18378979906969,0,0,0,0,0,0,0,0,0.124149428591716,0,0,0,0,0,0.134704106029175,0,0,0,0,0,0,0,0,0,0,0,0.320568492303233 | |||
|short_description=p@chr10:49880649..49880677,+ | |||
}} |
Latest revision as of 13:58, 23 July 2015
Short description: | p@chr10:49880649..49880677, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr10:49880649..49880677, + |
Coexpression cluster: | C782_B_Burkitt_lymphoma_splenic_acute_CD19_xeroderma |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 5.18e-98 | 24 |
pro-B cell | 5.18e-98 | 24 |
B cell | 1.66e-63 | 14 |
lymphoid lineage restricted progenitor cell | 9.97e-45 | 52 |
lymphocyte | 7.28e-44 | 53 |
common lymphoid progenitor | 7.28e-44 | 53 |
nongranular leukocyte | 2.02e-19 | 115 |
hematopoietic lineage restricted progenitor cell | 1.44e-18 | 120 |
leukocyte | 2.98e-16 | 136 |
B-1 B cell | 2.75e-15 | 1 |
hematopoietic oligopotent progenitor cell | 1.53e-13 | 161 |
hematopoietic multipotent progenitor cell | 1.53e-13 | 161 |
hematopoietic stem cell | 6.31e-13 | 168 |
hematopoietic cell | 3.33e-12 | 177 |
mature B cell | 2.67e-08 | 2 |
pre-B-II cell | 2.67e-08 | 2 |
transitional stage B cell | 2.67e-08 | 2 |
small pre-B-II cell | 2.67e-08 | 2 |
immature B cell | 2.67e-08 | 2 |
Ontology term | p-value | n |
---|---|---|
lymphoma | 7.85e-23 | 10 |
lymphatic system cancer | 2.75e-15 | 1 |
lymphosarcoma | 2.75e-15 | 1 |